Pre-/Post-Treatment Regulatory Cell Profiling of Human Tissue in Alopecia Areata
Study type:
Research Studies
Posting date:
11/12/2024
Last updated:
11/12/2024
Status:
Recruiting
Country:
United States
Eligibility:
Location:
University of California at San Francisco (UCSF)
1701 Divisadero Street
San Francisco, CA 94115
Description:
18 years or older; diagnosed with alopecia areata; about to start an oral JAK inhibitor; able to travel to UCSF for two in-person study visits
1701 Divisadero Street
San Francisco, CA 94115
Description:
Researchers at UCSF are studying how people with alopecia areata respond to current therapies with the hope of developing new and better treatments.
Study participants will be asked to donate a scalp biopsy and blood sample at two separate study visits, before and after starting on an oral JAK inhibitor medication.
Study participants may be compensated up to $350 for their time and effort.
You may qualify to participate in this study if you:
- Are 18 years of age or older and diagnosed with alopecia areata (AA)
- Are about to start an oral JAK inhibitor (i.e. baricitinib (Olumiant), ritlecitinib (Litfulo)) for treatment of your AA
- Are able to return to UCSF in San Francisco for a second study visit in ~4 months
For more information, contact Ashley Yates, PA by email at ashley.yates2@ucsf.edu